Nasal drops for treating neurodegenerative diseases
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This trial tests a nasal drop made from stem cell components. It may act directly in the brain to help slow or treat several conditions like Alzheimer's, Parkinson's, multiple system atrophy, dementia with Lewy bodies, or frontotemporal dementia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a confirmed diagnosis of one of the following: Alzheimer's, Parkinson's, multiple system atrophy, dementia with Lewy bodies, frontotemporal dementia, or ALS.
- For ALS: symptoms started between 6 months and 2 years ago.
- You can undergo MRI scans (no metal implants or severe claustrophobia).
- No recent or current other clinical trial participation (within 30 days).
- Not pregnant, breastfeeding, or planning to conceive during the trial or within 90 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a nasal drop made from tiny cell particles (extracellular vesicles) for ALS. The goal is to see if it's safe and if it can slow down the disease. It may be an option if your ALS is in the early to moderate stage.
This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.
This trial studies a new treatment for people with mild to moderate Alzheimer's disease. They take your own fat cells, turn them into stem cells, and inject them into the fluid around your brain. The hope is that these cells may help slow down memory loss.
This trial tests whether a single infusion of human mesenchymal stem cells (hMSC) can improve difficult behaviors like agitation, anxiety, or hallucinations in people with Alzheimer's disease. It's designed for those who have been taking antipsychotic medication for at least 4 weeks and have a study partner to help track behavior changes.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
Hear when a new Multiple System Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.